Clinical trials of topical antimicrobials have improved substantially over the past 20 years. Two decades ago, trials of these agents typically lacked “double blindness” and randomized allocation of medication. Many did not even have controls; comparisons were based on investigators’ impressions of what would have happened in the absence of treatment.
KeywordsPlacebo Expense Gentamicin Erythromycin Stake
Unable to display preview. Download preview PDF.
- 3.Allen AM Clinical trials in dermatology: Part 4, Analysis and interpretation. Int J Dermatol (to be published)Google Scholar
- 5.Esterley NB, Markowitz M The treatment of pyoderma in children. JAMA 212:1667–1670Google Scholar
- 6.Fleiss JC (1973) Statistical methods for rates and proporitons. John Wiley & Sons, New York 176–194Google Scholar
- 8.Kuflik EG, Howie CR, Nelson PI (1971) An evaluation of topical antifungal therapy in servicemen. Cutis 7:287–290Google Scholar
- 10.Mainland D (1963) Elementary Medical Statistics. 2nd ed. WB Saunders Co., Philadelphia, pp 368–370Google Scholar
- 12.Roberts SOB Champion RH (1968) Treatment of ringworm infections with tolnaftate ointment. Practitioner 199:797–798Google Scholar